Volume 9, Issue 2 (2024)
SJMR 2024, 9(2): 55-57 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nateghi M R. Exosomes: A Novel Frontier in Endometriosis Treatment. SJMR 2024; 9 (2) : 1
URL: http://saremjrm.com/article-1-331-en.html
URL: http://saremjrm.com/article-1-331-en.html
Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
Abstract: (1014 Views)
Introduction: Exosomes, nanosized extracellular vesicles secreted by various cell types, have emerged as promising therapeutic agents in diverse medical fields, including oncology, neurology, and reproductive health. In recent years, their potential in treating endometriosis—a chronic inflammatory disorder affecting reproductive-aged women—has garnered significant attention. Endometriosis, characterized by the presence of endometrial-like tissue outside the uterus, is often accompanied by chronic pelvic pain, infertility, and systemic inflammation. Despite advancements in medical and surgical interventions, treatment remains suboptimal, underscoring the need for novel approaches [1-3].
Article number: 1
Keywords: Endometriosis, Exosomes
Article Type: Letter to Editor |
Subject:
Women Diseases
Received: 2024/06/22 | Accepted: 2024/07/20 | Published: 2024/12/9
Received: 2024/06/22 | Accepted: 2024/07/20 | Published: 2024/12/9
References
1. Beetler DJ, Di Florio DN, Bruno KA, Ikezu T, March KL, Cooper LT, Jr., et al., Extracellular vesicles as personalized medicine. Mol Aspects Med, 2023. 91: 101155. [DOI:10.1016/j.mam.2022.101155] [PMID] []
2. Lopes D, Lopes J, Pereira-Silva M, Peixoto D, Rabiee N, Veiga F, et al., Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine. Military Medical Research, 2023. 10(1): 19. [DOI:10.1186/s40779-023-00453-z] [PMID] []
3. Chu X, Hou M, Li Y, Zhang Q, Wang S, Ma J, Extracellular vesicles in endometriosis: role and potential. Frontiers in Endocrinology, 2024. 15. [DOI:10.3389/fendo.2024.1365327] [PMID] []
4. Wagner M, Hicks C, El-Omar E, Combes V, El-Assaad F, The Critical Role of Host and Bacterial Extracellular Vesicles in Endometriosis. Biomedicines, 2024. 12.(11) [DOI:10.3390/biomedicines12112585] [PMID] []
5. Mosquera-Heredia MI, Morales LC, Vidal OM, Barceló E, Silvera-Redondo C, Vélez JI, et al., Exosomes: Potential Disease Biomarkers and New Therapeutic Targets. Biomedicines, 2021. 9.(8) [DOI:10.3390/biomedicines9081061] [PMID] []
6. Wang Y, Ma H, Zhang X, Xiao X, Yang Z, The Increasing Diagnostic Role of Exosomes in Inflammatory Diseases to Leverage the Therapeutic Biomarkers. J Inflamm Res, 2024. 17: 5005-5024.
7. Skuratovskaia D, Vulf M, Khaziakhmatova O, Malashchenko V, Komar A, Shunkin E, et al., Exosome Limitations in the Treatment of Inflammatory Diseases. Current Pharmaceutical Design, 2021. 27(28): 3105-3121. [DOI:10.2174/1381612826666201210120444] [PMID]
8. Fan M-H, Pi J-K, Zou C-Y, Jiang Y-L, Li Q-J, Zhang X-Z, et al., Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy. Bioactive Materials, 2024. 38: 1-30. [DOI:10.1016/j.bioactmat.2024.04.007] [PMID] []
9. Lee KWA, Chan LKW, Hung LC, Phoebe LKW, Park Y, Yi KH, Clinical Applications of Exosomes: A Critical Review. Int J Mol Sci, 2024. 25. (14) [DOI:10.3390/ijms25147794] [PMID] []
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
